Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma
Top Cited Papers
- 20 April 2007
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (12) , 1489-1497
- https://doi.org/10.1200/jco.2006.09.0936
Abstract
Purpose Hodgkin's lymphoma (HL) survivors are known to be at substantially increased risk of solid cancers (SC). However, no investigation has used multivariate modeling to estimate the relative risk (RR), excess absolute risk (EAR), and cumulative incidence for specific attained ages and ages at HL diagnosis. Patients and Methods We identified 18,862 5-year HL survivors from 13 population-based cancer registries in North America and Europe. Poisson regression was used to evaluate the effects of age at diagnosis, attained age, latency, sex, treatment, and year of diagnosis on the RR and EAR of SC. Results Among 1,490 identified SC, 850 were estimated to be in excess. For most cancer sites, both RR and EAR decreased with age at HL diagnosis and showed strong dependencies on attained age. For a patient diagnosed at age 30 years and survived to ≥ 40 years, modeled risks were significantly elevated for cancers of the breast (RR = 6.1), other supradiaphragmatic sites (RR = 6.0), and infradiaphragmatic sites (RR = 3.7); the largest RR (20-fold) was observed for malignant mesothelioma. Thirty-year cumulative risks of SC for men and women diagnosed at 30 years were 18% and 26%, respectively, compared with 7% and 9%, respectively, in the general population. For young HL patients, risks of breast and colorectal cancers were elevated 10 to 25 years before the age when routine screening would be recommended in the general population. Conclusion Multivariable modeling demonstrates for the first time temporal changes in SC risk not evident in unadjusted analyses, and can facilitate the development of individualized risk assessment and the creation of screening strategies for early detection.Keywords
This publication has 31 references indexed in Scilit:
- Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysisAnnals of Oncology, 2006
- Cancer Survivorship—Genetic Susceptibility and Second Primary Cancers: Research Strategies and RecommendationsJNCI Journal of the National Cancer Institute, 2006
- Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin LymphomaJNCI Journal of the National Cancer Institute, 2005
- Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term SurvivorsJNCI Journal of the National Cancer Institute, 2005
- ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term ResultsJournal of Clinical Oncology, 2004
- Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s DiseaseJournal of Clinical Oncology, 2003
- Long-term risk of second malignancy after treatment of Hodgkin’s disease: the influence of treatment, age andfollow-up timeAnnals of Oncology, 2002
- Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsBlood, 2002
- Tumors of the Brain and Nervous System after Radiotherapy in ChildhoodNew England Journal of Medicine, 1988